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Abstract Methyl tertiary-butyl ether (MTBE) is a synthetic
solvent widely used as oxygenate in unleaded gasoline. Few
studies have addressed the cellular toxicity of MTBE on some
cell lines, and so far, no comprehensive study has been con-
ducted to investigate the probable immunotoxicity of this
compound. In this study, the toxicity of MTBE on human
blood lymphocytes was evaluated. Blood lymphocytes were
isolated from healthy male volunteers’ blood, using Ficoll
polysaccharide followed by gradient centrifugation. Cell via-
bility, reactive oxygen species (ROS) formation, lipid perox-
idation, glutathione levels, and damage to mitochondria and
lysosome were determined in blood lymphocytes after 6-h
incubation with different concentrations of MTBE (0.1, 0.5,
1, and 2 mM). Our results showed that MTBE, in particular,
decreased cell viability, which was associated with significant
increase at intracellular ROS level and toxic alterations in
mitochondria and lysosomes in human blood lymphocytes.
Moreover, it was shown that MTBE strongly provoked lipid
peroxidation and also depleted glutathione level at higher con-
centrations. Interestingly, MTBE exhibited its cytotoxic
effects at low concentrations that may resemble to its concen-
trations in human blood following occupational and environ-
mental exposure. It is therefore concluded that MTBE was
capable of inducing oxidative stress and damage to mitochon-
dria and lysosomes in human lymphocytes at concentrations
ranging from 5 to 40 μg/L, which may be present in human
blood as a result of environmental exposure.
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Introduction
Methyl tertiary-butyl ether (MTBE) belongs to a large family
of oxygenated ethers such as methyl tertiary amyl ether and
ethyl tertiary butyl that came into use as motor vehicle fuel
additives in the late 1970s with a significant increase in the
1990s (Sgambato et al. 2009). MTBE is used as an additive to
oxygenate gasoline to improve air quality by reducing tailpipe
emissions of ozone precursors and carbon monoxide. Due to
its enormous production, widespread use, and improper dis-
posal of used motor oil, MTBE has been found in urban storm
runoff and streams, lakes, and groundwater. Then, potential
for human exposure is high (Dong-Mei et al. 2009). MTBE
pollution is considered as a critical environmental problem. It
is often found at contaminated sites and is thought to be harm-
ful to human health. Exposure to MTBE has been a long time
concern in many occupational fields, including gasoline trans-
port by tanker lorries, service stations, policemen, and the
petroleum industry. Traffic policemen and gas station workers
are two of the groups most heavily exposed to vehicle ex-
hausts during their work shifts (Egeghy et al. 2000, Crebelli
et al. 2001, Scibetta et al. 2004). According to literature, in
estimation of workers’ exposure with biological samples,
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analysis of the concentration of MTBE in urine detected after
the work shift seems to give the most reliable estimation of
exposure (Saarinen et al. 1998, Hakkola et al. 2001, Vainiotalo
et al. 2006). Increasing use of these oxygenates together with
concerns about the effects of oxygenated fuels on human
health has prompted research efforts in several fields (Nihlén
et al. 1998, Alimohammadi et al. 2005, Khavanin et al. 2005,
Nikpey et al. 2006, Tomei et al. 2006, Silva et al. 2008, Dong-
Mei et al. 2009). Many in vitro and in vivo studies have re-
ported the adverse effect of MTBE on experimental animals
(Li et al. 2007, de Peyster et al. 2008, Dong-Mei et al. 2009, Li
et al. 2009, Pourahmad et al. 2012), while there was not wide
evidence to show that the uses of MTBE have imposed sig-
nificant harmful effects on human health. Acute exposures to
MTBE have reported to cause a variety of symptoms includ-
ing nausea; headaches; nose, throat, and eye irritation (Fiedler
et al. 2000). Some animal exposure studies have also reported
the carcinogenicity of MTBE. Environmental Protection
Agency (EPA) has classified MTBE as a potential human
carcinogen. Besides, several toxicity studies related to
MTBE revealed that MTBE could exert toxic effects on cul-
tured spermatogenic cells (Li and Han 2006, Li et al. 2007),
cause DNA damage on mice fibroblasts (Song et al. 2002),
and induce cell transformation in cultured rodent fibroblasts
(Iavicoli et al. 2001).
Peripheral blood lymphocytes are exposed to gases and
particulate matter present in the atmosphere. Exposure to pol-
luted air containing MTBE is therefore suspected to induce
damage to human blood lymphocytes. Immunotoxicity stud-
ies on rats have shown that fuel oxygenates including MTBE
have toxic effect on immune system (White et al. 2014).
Addition to in vivo study performed on rats has shown that
MTBE exerted toxicity on white blood cell count, including
lymphocyte, granulocyte, and eosinophil (Dong-Mei et al.
2009). Human study among gasoline station attendants indi-
cated that immune reactions to MTBE do occur through hap-
ten carrier reactions which, in some individuals, end with spe-
cific 1gG and IgM production (Vojdani et al. 1997b). The
current study was therefore designed to evaluate whether iso-
lated blood lymphocytes obtained from healthy donors are
vulnerable to exposure to MTBE concentrations. The second
objective of this study was to investigate the cytotoxicity
mechanisms involved in possible MTBE-induced human
blood lymphocytes.
Materials and methods
Chemicals
Rhodamine 123, collagenase, bovine serum albumin (BSA),
N-(2-hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid)
(HEPES), acridine orange, 2′,7′-dichlorofuorescin diacetate
(DCFH-DA), trichloroacetic acid, trypan blue, MTBE, and
RPMI 1640 were purchased from Sigma-Aldrich Co.
(Taufkirchen, Germany). All other chemicals were of the
highest commercial grade available.
Blood samples and ethics statement
All blood samples (n= 25) were acquired from Massoud
Laboratory and approved by Blood Administration Center of
Tehran Province. The studies were performed at the Faculty of
Pharmacy, Shahid Beheshti University of Medical Sciences,
under the guidance of an expert physician. This study was
approved by the Shahid Beheshti University of Medical
Sciences research ethics committee, and all healthy donors
signed an informed consent form.
Lymphocyte isolation
Lymphocytes were collected from healthy donor at age range
25 to 35 years old. Blood was obtained from 25 healthy, non-
smoking volunteers, who showed no signs of infection disease
symptoms at the time that the blood samples were collected.
Lymphocytes were isolated using Ficoll Paque Plus by centri-
fugation at 2500g for 20 min at 25 °C. Lymphocytes were
collected, suspended in erythrocyte lysis buffer (150 mM
NH4Cl, 10 mM NaHCO3, 1 mM EDTA, 183 pH 7.4), and
incubated for 5 min at 37 °C. Then, PBS was added immedi-
ately, and the cells were centrifuged at 1500g for 10 min at
20 °C. The supernatant was decanted, and the cells were
washed twice with RPMI with L-glutamine and 10 % fetal
bovine serum (FBS) at 2000g for 7 min. The cells were resus-
pended in RPMImediumwith L-glutamine and 10% FBS and
counted in hemocytometer. The final lymphocyte density used
in the experiments was 1×106 cells/ml. The viability of the
cells was over 95 %.
Lymphocyte treatment
MTBE dissolved in DMSO. The final concentration of
DMSO in negative control samples (withoutMTBE) and sam-
ples treated with individual MTBE was 0.05 % during analy-
sis of all parameters. The concentrations of DMSO used in the
experiments (samples) were not toxic for lymphocytes as an-
alyzed by cell viability and other parameters. The changes in
untreated cells (negative controls) were referred to as 100 %.
The final concentrations of the compounds used in the exper-
iments were in the range from 0.1, 0.5, 1, and 2 mM. The cells
were incubated with MTBE for 6 h to analyze cell viability,
and oxidative stress mechanistic parameters were studied
within 3 h of incubation. The incubation was performed at
37 °C in 5 % CO2 atmosphere in the total darkness.
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Cell viability
Cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,
5-diphenyl tetrazolium bromide (MTT) staining as described
by Mosmann (1983). The MTT assay is based on the reduc-
tion of the tetrazolium salt, MTT, by viable cells. The dehy-
drogenases using NADH or NADPH as co-enzyme can con-
vert the yellow form of the MTT salt to insoluble, purple
formazan crystals (Liu et al. 1997). Formazan solution is read
spectrophotometrically after the crystals are dissolved in or-
ganic solvent (DMSO). Lymphocytes (1×104cells/well) were
incubated in 96-well plates in the presence or absence of
MTBE for 6 h in a final volume of 50 μl. At the end of the
treatment, 25 μl of MTT (5 mg/ml in RPMI) was added to
each well and incubated for an additional 2 h at 37 °C. The
purple-blue MTT formazan precipitate was dissolved in
100 μl of DMSO, and the absorbance was measured at
570 nm with ELISA reader. Each concentration was tested
in three different experimental runs in three replicates for each
sample.
Determination of reactive oxygen species
To determine the rate of lymphocyte reactive oxygen species
(ROS) generation induced by MTBE, dichlorofluorescein
diacetate (DCFH-DA, 1.6 μM) was added to the lymphocytes.
It penetrates PBMC cells and becomes hydrolyzed to non-
fluorescent dichlorofluorescein (DCFH). The latter then reacts
with ROS to form the highly fluorescent dichlorofluorescein
(DCF), which effluxes the cell. The fluorescence intensity of
DCF was measured using a Shimadzu RF5000U fluorescence
spectrophotometer. Excitation and emission wavelengths were
500 and 520 nm, respectively. The results were expressed as
fluorescent intensity per 106 cells (Pourahmad et al. 2011a).
Mitochondrial membrane potential assay
Mitochondrial uptake of the cationic fluorescent dye, rhoda-
mine 123 (1.5 μM), has been used for the determination of
mitochondrial membrane potential in human blood
lymphocytes (Pourahmad et al. 2009). The amount of rhoda-
mine 123 remaining in the incubation medium was measured
fluorimetrically using a Shimadzu RF5000U fluorescence
spectrophotometer set at 490-nm excitation and 520-nm emis-
sion wavelengths. The capacity of mitochondria to uptake the
rhodamine 123 was calculated as the difference (between con-
trol and treated cells) in rhodamine 123 fluorescence (Rezaei
et al. 2008).
Lysosomal membrane integrity assay
Lymphocyte lysosomal membrane stability was determined
from the redistribution of the fluorescent dye, acridine orange,
from lysosomes into cytosol (Pourahmad et al. 2010).
Aliquots of the cell suspension (0.5 ml) that were previously
stained with acridine orange (5 μM) were separated from the
incubation medium by 1-min centrifugation at 1000 rpm. The
cell pellet was then resuspended in 2 ml of fresh incubation
medium. This washing process was carried out twice to re-
move the fluorescent dye from the media. Acridine orange
redistribution in the cell suspension was then measured
fluorimetrically using a Shimadzu RF5000U fluorescence
spectrophotometer set at 495-nm excitation and 530-nm emis-
sion wavelengths. Lysosomal membrane damage was deter-
mined as the difference in redistribution of acridine orange
from lysosomes into cytosol between treated lymphocytes
and control lymphocytes at the time of preparation
(Pourahmad et al. 2011b; Pourahmad et al. 2012).
Lipid peroxidation
Evaluation of lipid peroxidation in lymphocytes was conduct-
ed by determination of the amount of thiobarbituric acid reac-
tive substances (TBARS) formed during the decomposition of
lipid hydroperoxides by following the absorbance at 532 nm
in a Beckman DU-7 spectrophotometer (Seydi et al. 2015).
GSH and GSSG
Reduced glutathione (GSH) and oxidized glutathione (GSSG)
were determined according to the spectrofluorometric method
(Hissin and Hilf 1976). Each sample was measured in quartz
cuvettes using a fluorimeter set at 350-nm excitation and 420-
nm emission wavelengths (Pourahmad et al. 2000).
Statistical analysis
Results are presented as mean±SD. Assays were performed
in triplicate, and the mean was used for statistical analysis.
Statistical significance was determined using the one-way
and two-way ANOVA tests, followed by the post hoc Tukey
and Bonferroni tests, respectively. Statistical significance was
set at P<0.05. In all graphs, the results were expressed as
mean ± SD and P < 0.05 was considered statistically
significant.
Results
Cell viability
For determination of cytotoxicity of MTBE on lymphocytes,
we used MTT assay. Our results showed that even at the low-
est concentration (0.1 mM), MTBE has toxic effect toward
lymphocytes. As shown in Fig. 1, MTBE at concentrations
of 0.1, 0.5, 1, and 2 mM significantly (P<0.001) reduced cell
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viability down to 9.4, 22, 47, and 61 %, respectively (Fig. 1).
The IC50 measured for MTBE on lymphocytes was 1 mM.
Determination of ROS
In our study, we tested the effect of MTBE on ROS formation
at time intervals (30, 120, and 180); we used 0.1-, 0.5-, and 1-
mM concentration of MTBE.
Besides, when human blood lymphocytes were incubated
with MTBE at different concentrations of 0.1, 0.5, and 1 mM,
ROS formation (determined by the oxidat ion of
dichlorofluorescein to dichlorofluorescein) was also signifi-
cantly (P<0.05) raised. MTBE (0.5 mM)-induced ROS for-
mation was significantly prevented by butylated
hydroxytoluene (BHT) (Fig. 2).
Determination of MMP
Mitochondrial membrane potential, which is a highly sensi-
tive indicator of the mitochondrial inner membrane condition,
was measured by rhodamine 123 redistribution. As shown in
Fig. 3, matrix metalloproteinase (MMP) significantly
(P<0.05) decreased in lymphocytes of MTBE-treated group
compared with untreated control group (Fig. 3). The mito-
chondrial membrane potential in two groups was measured
in the time intervals of 30, 120, and 180 min. Furthermore,
5μMcyclosporine A (anMPT blocker) and 50μMBHTas an
antioxidant strongly inhibited the decline of MMP in lympho-
cytes exposed to 0.5 mM of MTBE (P< 0.05). An MPT
inducer, CaCl2 (50 μM), was also used as a positive control
in MMP assay (Fig. 3).
Lysosomal membrane integrity assay
When lymphocytes lysosomes were loaded with acridine or-
ange (a lysosomotropic agent), a significant release of acridine
orange ensued into the cytosolic fraction within 180 min of
incubation with MTBE indicating severe damage to lysosom-
al membrane (Fig. 4). MTBE -induced acridine orange release
was again prevented by BHT and chloroquine (100 μM). All
of these reagents did not induce any marked effects on acri-
dine orange redistribution from lysosomes to cytosol at con-
centrations used (data not shown).
Lipid peroxidation
As shown in Fig. 5, a significant amount of TBARS was
formed when incubated with different concentrations of
MTBE (0.1, 0.5, and 1 mM). MTBE-induced TBARS forma-
tion was prevented by ROS scavenger (BHT 50 μM) and
MPT pore sealing agent (Cs.A 5 μM). MTBE-induced lipid
peroxidation was also inhibited by GSH (Fig. 5).
GSH and GSSG
As shown in Fig. 6, incubation of lymphocytes with MTBE
produced rapid lymphocytes GSH depletion. Most of the
MTBE-induced GSH depletion may be attributed to the ex-
pulsion of GSSG (Fig. 6b). Again, antioxidant (BHT), MPT
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Fig. 1 Determination of cell
viability in MTBE-treated human
lymphocytes. Lymphocytes from
healthy donors, at 1 × 104 cells/
well, were seeded on 96-well
plates. MTBE at 0.1-, 0.5-, 1-, and
2-mM concentrations was incu-
bated in human lymphocytes for
6 h. The absorbance representing
the viability decrease in lympho-
cytes was determined by the
ELISA reader at 570 nm. Data
presented as mean ± SD (n = 5).
The significant level was set at
P< 0.05
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Fig. 2 Determination of ROS
formation in MTBE-treated hu-
man lymphocytes. ROS forma-
tion was measured
fluorometrically using DCF-DA
as described in BMaterials and
methods^ section. Values are
presented as mean ± SD (n = 3).
***P< 0.0001 significant differ-
ence compared to untreated
control
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Fig. 3 Determination of MMP
collapse in MTBE-treated human
lymphocytes. Collapse of MMP
was measured by rhodamine 123
as described in BMaterials and
methods^ section. Cs.A and BHT
inhibited the decline of MMP in
lymphocytes exposed to MTBE
(0.5 mM) (P< 0.05). Ca+2 was
used as a positive control inMMP
assay. Values represented as per-
centage of mitochondrial mem-
brane potential decline (n= 3).
***Significant difference
(P< 0.0001) compared to un-
treated control
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Fig. 4 Determination of
lysosomal membrane damage in
MTBE-treated human lympho-
cytes. Lysosomal membrane dam-
age was determined as the differ-
ence in redistribution of acridine
orange from lysosomes into cyto-
sol between the treated lympho-
cytes and untreated control lym-
phocytes. Results were shown as%
lysosomal membrane leakiness in
all treated (test) lymphocyte
groups. Values are expressed as
mean±SD of three separate ex-
periments (n=3). ***Significant
difference in comparison with
control lymphocytes (P<0.001).
***Significant difference in com-
parison with MTBE-treated lym-
phocytes (P<0.001)
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Fig. 5 Determination of lipid
peroxidation in MTBE-treated
human lymphocytes. Lympho-
cytes (106 cells/ml) were incubat-
ed in the RPMI 1640 at 37 °C for
180 min following the addition of
MTBE. TBARS formation was
expressed as nanomolar concen-
trations. Values are expressed as
mean ± SD of three separate ex-
periments (n= 5). ***Significant
difference in comparison with
untreated control lymphocytes
(P< 0.001). ###Significant dif-
ference in comparison with
MTBE-treated lymphocytes
(0.5 mM) and preventive agent
(BHT, GSH, and Cs.A)
(P< 0.001)
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pore-sealing agents (Cs.A), lysosomotropic agents
(chloroquine) significantly prevented bothMTBE-induced in-
tracellular GSH decrease and extracellular GSSG increase
(Fig. 6). All of these reagents did not produce any significant
effects on lymphocytes GSH/GSSG status at concentrations
used (data not shown).
Discussion
Considering the fact those potential toxic effects of chemicals
on the immune system arises from the critical role of this
system in maintaining health. It is well recognized that sup-
pressed immunological function can result in increased inci-
dence and severity of infectious diseases as well as some types
of cancer (Reiche et al. 2004). Quite in contrast, inappropriate
enhancement of immune function or the generation of
misdirected immune responses can precipitate or exacerbate
development of allergic and autoimmune diseases (Griem et
al. 1998). Thus, both suppression and enhancement of im-
mune function are considered to represent potential
immunotoxic effects of chemicals (Gleichmann et al. 1989).
The aim of this study was to search the possible toxic effect of
MTBE on blood lymphocytes that are important components
in immune system. In this investigation the cellular toxicity
endpoints such as viability decrease, lipid peroxidation, in-
creased ROS formation, collapse of MMP and lysosomal
membrane leakiness were tested in human blood lymphocytes
following the addition of different concentrations of MTBE.
Moreover, the effect of this substance on anti oxidant status
most importantly intracellular GSH and extracellular GSSH
levels was assessed.
According to our knowledge, no other comprehensive re-
search has so far been conducted to evaluate the possible tox-
icity of MTBE on human lymphocytes and its mechanisms, in
spite of some laboratory reports, which suggested that MTBE
may affect the blood cells either by stimulating or inhibiting
the activity of some cellular components (Pleil 2009).
We observed that MTBE caused statistically significant
decrease in cell viability even at 0.1 μM after 6 h of incuba-
tion, which showed its cytotoxic potential towards human
blood lymphocytes (Fig. 1). Previous studies also showed that
MTBE could cause cytotoxic effect on several cell lines (Li et
al. 2007).
Our findings regarding oxidative stress parameters re-
vealed that MTBE could increase ROS production and en-
hance lipid peroxidation (Figs. 2 and 5). The increased ROS
production may play a significant role in the enhancement of
lipid peroxidation and finally cellular and sub cellular mem-
brane damage.
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Fig. 6 Determination of intracellular GSH and extracellular GSSG in
MTBE-treated human lymphocytes. Lymphocytes (106 cells/ml) were
incubated in the RPMI 1640 at 37 °C for 180 min following the addition
of MTBE. Intracellular GSH (a) and extracellular GSSG ( b) were
fluorimetrically determined. Values are expressed as mean ± SD of three
separate experiments (n = 5). ***Significant difference in comparison
with untreated control (P< 0.001). ###Significant difference in compar-
ison with MTBE-treated lymphocytes and preventive agent (P< 0.001)
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Mitochondria are deeply involved in the production of
ROS through one-electron carriers in the respiratory chain;
mitochondrial structures are also very susceptible to oxidative
stress. Our results proved that MTBE could cause mitochon-
drial damage which could be prevented by antioxidant (BHT)
and MPT pore-sealing agents (Cs.A) (Fig. 3). Also mitochon-
dria damages may lead to release of proapoptotic agents from
mitochondria to cytosol and finally induce apoptosis through
mitochondria pathways related to oxidative stress induced by
MTBE. Moreover previous study on human blood lympho-
cyte by Vojdani et al. showed apoptotic effect (Vojdani et al.
1997a). GSH is an intracellular antioxidant that prevents an
intracellular ROS formation and lipid peroxidation. As an an-
tioxidant, it has been involved in cell protection from delete-
rious effects of the oxidative stress, both directly and as a
cofactor of glutathione peroxidases, and these reactions gen-
erate GSSG (Pompella et al. 2003). Thus, the GSH depletion
is a marker of the cellular oxidative stress and may be attrib-
uted to the expulsion of GSSG. Our results showed that when
lymphocytes were incubated with MTBE, the GSH depletion
occurred as a consequence of the ROS formation and the lipid
peroxidation. These results are agreement with previous study
(Pourahmad et al. 2012) suggesting that the MTBE-induced
toxicity was related to decrease in the GSH content.
When lymphocyte lysosomes were loaded with acridine
orange, a massive redistribution of acridine orange into the
cytosolic fraction ensued within 180 min when the loaded
lymphocytes were treated with MTBE, indicating leakiness
of the lysosomal membrane (Fig. 4). On the other hand, the
MTBE-induced acridine orange release was prevented by the
lysosomotropic agent (chloroquine) and a ROS scavenger
(BHT), suggesting involvement of pH-dependent
intralysosomal Fenton’s type reactions and ROS formation
in MTBE-induced lysosomal membrane damage in human
lymphocytes.
All our data was in favor of the involvement of the oxida-
tive stress hypothesis in MTBE-induced human blood lym-
phocyte cytotoxicity, since both the decline in MMP and ly-
sosomal membrane labilization were ensued following the
MTBE-induced ROS formation, the lipid peroxidation, and
the GSH depletion in blood lymphocytes. It is assumed that
the oxidative stress causes damage on mitochondrial and ly-
sosomal membranes through lipid peroxidation, which ulti-
mately leads to cell death.
Conclusion
Results of this study suggest that MTBE decreases cell viabil-
ity, which is associated with significant increase at intracellu-
lar reactive oxygen species (ROS) level and toxic alterations
in mitochondria and lysosomes in human blood lymphocytes.
These mentioned effects trigger depleted glutathione and lipid
peroxidation. Moreover, MTBE showed its cytotoxic effects
at low concentrations that may resemble to its concentrations
in human blood following occupational and environmental
exposure. It is therefore concluded that MTBE was capable
of inducing oxidative stress and damage to mitochondria and
lysosomes in lymphocytes at concentrations ranging from 5 to
40 μg/L, which may be present in human blood as a result of
environmental and occupational exposure.
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